(Washington, D.C.)—Washington Legal Foundation (WLF) and the Chair of its Legal Policy Advisory Board, Jay B. Stephens, are pleased to announce that Professor John Yoo of the University of California,...
On February 11, 2026, the Western District of Texas preliminarily enjoined enforcement of a Texas law compelling misleading warning labels on food products. The decision was a victory for WLF,...
An FDA regulation requiring dramatically expanded disclosure of side effects and counterindications in direct-to-consumer drug ads would not, after Loper Bright, survive a legal challenge alleging that the agency is exceeding its statutory authority.
August 14, 1992
Issues:
By Richard A. Samp, Chief Counsel of WLF.
By visiting our website, you agree to the use of tracking technologies, such as cookies, to improve site functionality, analyze web traffic, and record how you interact with our website.